Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
Abstract Background Little data exists predicting the resistance to actinomycin D (Act-D) single-agent for gestational trophoblastic neoplasia (GTN). The objective was to determine the overall success of pulse Act-D and the factors predictive of resistance to pulse Act-D in the treatment of low-risk...
Main Authors: | Lei Li, Xirun Wan, Fengzhi Feng, Tong Ren, Junjun Yang, Jun Zhao, Fang Jiang, Yang Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4512-5 |
Similar Items
-
Outcome of pregnancy subsequent to chemotherapy with actinomycin-D in low risk gestational trophoblastic neoplasia
by: Soheila Aminimoghaddam, et al.
Published: (2017-07-01) -
Low-risk gestational trophoblastic neoplasia: A single-center experience from Saudi Arabia
by: Abdulaziz Alobaid, et al.
Published: (2019-07-01) -
Gestational trophoblastic neoplasia: A 6 year retrospective study
by: Sushruta Shrivastava, et al.
Published: (2014-01-01) -
Uterine choriocarcinoma - a case report
by: Vanda Paradžik-Pašalić, et al.
Published: (2021-01-01) -
Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017
by: Yujia Kong, et al.
Published: (2020-04-01)